XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net revenue $ 984 $ 555 $ 4,138 $ 713
Cost of revenues 860 601 2,948 1,139
Cost of revenues – amortization of acquired intangibles 990 2,371
Gross profit (866) (46) (1,181) (426)
Operating expenses:        
Research and development 3,142 2,615 9,040 8,000
Sales and marketing 2,931 1,568 7,858 4,620
General and administrative 5,495 4,995 18,193 13,378
Change in fair value of contingent consideration 1,170 (2,980) 2,260 (2,980)
Total operating expenses 12,738 6,198 37,351 23,018
Loss from operations (13,604) (6,244) (38,532) (23,444)
OTHER INCOME (EXPENSES), NET        
Interest expense, net (50) (78) (167) (175)
Unrealized gain (loss) on marketable equity securities (138) 20 248 (18)
Pro rata loss from equity method investment in Razor (482) (270) (1,112)
Gain on extinguishment of debt (PPP loan) 1,141
Other income, net (8) 1 10 31
Total other income (expenses), net (196) (539) 962 (1,274)
LOSS BEFORE INCOME TAXES (13,800) (6,783) (37,570) (24,718)
Income tax benefit 9,358 1,095
NET LOSS $ (13,800) $ (6,783) $ (28,212) $ (23,623)
Net loss per share: basic and diluted $ (0.15) $ (0.10) $ (0.32) $ (0.36)
Weighted average shares outstanding: basic and diluted 91,453 67,247 87,812 64,843